Adial Pharmaceuticals Appoints Celia Economides as Chief Financial Officer
Adial Pharmaceuticals (ADIL) has announced the upcoming appointment of Celia Economides to the position of Chief Financial Officer. Economides currently serves as the company's Executive Vice President of Finance. The transition is scheduled to take effect promptly following the conclusion of the company's reconvened 2026 annual meeting of stockholders. This leadership change marks a formalization of financial oversight within the organization.
Tickers: $ADIL
Topics: C-suite changes leadership transition
Read the full article at Seeking Alpha
Part of the story YA Group Appoints Jeff Calcagno as Chief Financial Officer (5 articles)